Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN118851951A details a one-pot synthesis for aryl cyano hypervalent iodine salts, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel Ni(II)-catalyzed method for high stereoselectivity 1,2-cis-glycosides. Reduces steps, improves yield, offers cost-effective API intermediate manufacturing.
Patent CN113214051A details a green synthesis of 2,6-dihydroxytoluene using waste acid recycling, boosting yield to 90% and purity to 99.5% for pharma applications.
Patent CN102978272B reveals enzymatic synthesis for water soluble phytosterols. Enhances bioavailability and supply chain reliability for nutritional ingredients manufacturing.
Advanced synthesis of rigid adamantane ligands via patent CN102153510A. Offers cost reduction in fine chemical manufacturing and scalable production for coordination chemistry applications.
Patent CN102040572A details a green synthesis of benzofuranone using cationic resin, offering high purity and reduced corrosion for azoxystrobin manufacturing.
Patent CN107827756A reveals catalyst reducing N-methyl impurities. Enhances supply chain reliability and cost efficiency for global buyers.
Patent CN104059023A offers eco-friendly Vitamin B1 intermediate synthesis. Reduces carcinogens, improves purity, ensures supply chain stability for global buyers.
Novel copper-catalyzed route for high-purity tetrahydropyridine boronates offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN1263729C reveals a safe FeCl3-catalyzed hydrazine reduction for 3,4'-diaminodiphenyl ether, eliminating high-pressure risks and vacuum distillation for cost-effective polyimide monomer manufacturing.
Patent CN1166646C reveals a mild organophosphine-catalyzed route to piperazines and morpholines, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN113862708A reveals a metal-free electrochemical route for beta-cyano compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis patent CN119775253B offers high-yield safe production. Reliable supplier for cost reduction in flavor manufacturing.
Patent CN101805277B reveals a liquid-phase SO2 method for high-purity 2,2'-dithiosalicylic acid, offering significant cost and environmental advantages for pharmaceutical intermediates.
Patent CN110143904A reveals ionic liquid microwave isomerization for zeaxanthin. This method reduces solvent use and enhances safety for scalable nutritional ingredient manufacturing.
Novel one-step chlorination process reduces cost and waste for dye and polymer intermediates supply chain efficiency and purity standards globally.
Patent CN115286608A reveals a high-yield, base-catalyzed route for benzopyran compounds, offering cost reduction in pharmaceutical intermediate manufacturing and superior functional group tolerance.
Patent CN111196786B details a novel copper-catalyzed route for trifluoromethanesulfonyl isoxazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN103980160B details mild IPDC synthesis. Offers supply chain stability and cost reduction in fine chemical intermediates manufacturing.
Novel patent CN104910195B enables efficient difluoromethylation. Stable solid reagent offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.